Nitromint (Glyceryl Trinitrate)

Glyceryl trinitrate, the active ingredient in Nitromint, is a nitrate vasodilator presented as a sublingual tablet for sublingual administration. It rapidly relieves chest pain by improving myocardial oxygen supply and is indicated for acute angina pectoris and for prophylaxis of angina attacks in adult patients.

GNH USA supplies Nitromint as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures reliable delivery, regulatory compliance, and quality assurance across multiple regions. We adhere to stringent GMP standards and provide comprehensive product documentation to support clinical use.

Nitromint (glyceryl trinitrate) is used in the management of coronary artery disease‑related chest pain.

Acute angina pectoris: provides rapid relief of chest pain by dilating coronary vessels. Prophylaxis of angina attacks: reduces the frequency of episodes by decreasing cardiac workload. Exercise‑induced angina: improves tolerance to physical exertion by enhancing myocardial oxygen delivery.

Nitromint may cause a range of adverse reactions, most of which are related to its vasodilatory action.

Common Side Effects: - Headache: throbbing pain often occurring shortly after administration. - Flushing: warmth and redness of the face and neck. - Dizziness or light‑headedness. - Hypotension: transient drop in blood pressure. - Nausea or mild gastrointestinal discomfort. - Palpitations: awareness of heartbeat.

Serious or Rare Side Effects: - Severe hypotension leading to syncope. - Methemoglobinemia: reduced oxygen‑carrying capacity of blood. - Allergic reactions such as rash, bronchospasm, or angioedema. - Reflex tachycardia: rapid heart rate in response to blood‑pressure fall. - Ischemic stroke (very rare). - Cardiovascular collapse in patients with pre‑existing severe cardiac dysfunction.

When prescribing Nitromint, clinicians should consider several safety measures.

Dose titration: start with the lowest effective dose under medical supervision. Avoid concurrent use of phosphodiesterase‑5 inhibitors: may cause profound hypotension. Monitor blood pressure: check before and after each dose. Educate patient on proper sublingual placement and avoid swallowing the tablet. Pregnancy and lactation: use only if benefits outweigh potential risks (category unknown). Store at ambient temperature: keep below 25 °C, retain in the original container, and protect from moisture and light.

Nitromint interacts with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil): risk of severe hypotension. - Other nitrates or nitric‑oxide donors: additive vasodilation leading to dangerous blood‑pressure fall. - Sodium nitroprusside: excessive vasodilatory effect.

Moderate Interactions (Monitor Closely): - Antihypertensives (beta‑blockers, ACE inhibitors, ARBs): may enhance blood‑pressure lowering. - Diuretics: increase risk of orthostatic hypotension. - Alcohol: can potentiate vasodilatory effects and dizziness.